Effect of Quercetin on Diabetic Rat | ||||
| SVU-International Journal of Medical Sciences | ||||
| Article 67, Volume 6, Issue 2, July 2023, Page 708-728 PDF (1.22 MB) | ||||
| Document Type: Original research articles | ||||
| DOI: 10.21608/svuijm.2023.225835.1628 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Nada H. H. Abdel-Tawab1; Hosny A. Hassan2; Nesma M. Mohamed3; Nashwa H. Hamad4; Michel E. Fakhry  2
| ||||
| 1Biochemistry Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt | ||||
| 2Medical Biochemistry Department, Faculty of Medicine, Assiut University, Assiut, Egypt | ||||
| 3Pharmacognosy Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt & Pharmacogosy Department, Faculty of Pharmacy, Badr University in Assiut (BUA), Assiut, Egypt | ||||
| 4Pathology and Clinical Pathology Department, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt. | ||||
| Abstract | ||||
| Background: Quercetin (QR) is one of the major constituents of the methanolic extract of the leaves of Psidium guajava (Guava leaves). Objectives: The work’s aim is to understand the Quercetin’s mechanism in improving insulin resistance, use the homeostasis model assessment for insulin resistance (HOMA-IR) to determine the influence of quercetin on glycemic control, Look at how quercetin affects diabetes-related lipid metabolism and lipid profile measures. Analyze the impact of QR on oxidative stress in diabetic rats and contrast its antidiabetic effects whether administered as a nutrient or supplement. Materials and methods: Sixty adult male Wister rats that were matched in age and had starting body weights between 150 and 200 g were used in this study. One normoglycemic control group and 3 diabetic control groups (15 rats per group) were used. The diabetic control rats received the vehicle orally as saline daily, the normoglycemic control group received quercetin orally in a dose of 50 mg/kg per day, and the diabetic rats received quercetin orally in a dose of 100 mg/kg per day. Results: After six weeks of therapy, the rats with diabetes receiving isolated quercetin at doses of 50 and 100 mg/kg had reduced blood glucose levels, and their triglyceride, low-density lipoprotein, and total cholesterol profiles all significantly improved. Also, there was significant decrease homeostatic model assessment for insulin resistance, serum transaminases, hepatic malondialdehyde, and HMG CoA expression in liver and a substantial rise in levels of insulin, hepatic GSH, and insulin receptor substrate (IRS2) expression & Phosphoinositide 3-kinases in liver as compared to those of control group, but non- significance changes in high-density lipoprotein, AKT expression in liver were observed. Conclusions: Quercetin could be considered as a potential hypoglycmeic medication with possible mechanisms controlling the hyperglycemic state and cholesterol, triglycerides and LDL levels. | ||||
| Keywords | ||||
| Quercetin; Rat with diabetes; lipid profile; HOMA-IR | ||||
|
Statistics Article View: 172 PDF Download: 181 |
||||
